spr720
spr720: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Spero Therapeutics, Inc. (SPRO) | Phase 2 |
Clinical Trials (1)
A Randomized, Investigator-Blinded, Placebo-Controlled, Multicenter, Phase 2, Dose-Ranging Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared With Placebo for the Treatment of Patients With Mycobacterium Avium Complex (MAC) Pulmonary Disease
Frequently asked questions
Who is developing spr720?
spr720 is being developed by Spero Therapeutics, Inc..
How many clinical trials involve spr720?
BioSniper tracks 1 clinical trial involving spr720.
Get deeper analysis on spr720
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis